Eledon Pharmaceuticals, Inc.
DE ˙ DB ˙ US28617K1016
2,92 € ↓ -0,04 (-1,35%)
2026-06-04
AKTIENPREIS
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership87,472 shares
Latest Disclosed Value $ 132,082
Barclays Plc reports 9.68% increase in ownership of 2TK / Eledon Pharmaceuticals, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 87,472 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $111,964 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 79,753 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of 9.68% during the quarter. The current value of the position is $255,418 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 87,472 7,719 9.68 132 -35.92 0.0000
2026-03-31 2025-09-30 13F/A-3 ELEDON PHARMACEUTICALS COM 28617K101 79,753 -22,125 -21.72 207 -25.36 0.0000
2025-11-12 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 79,753 -22,125 207 0.0000
2026-02-27 2025-06-30 13F/A-2 ELEDON PHARMACEUTICALS COM 28617K101 101,878 31,878 45.54 276 16.46 0.0001
2025-08-14 2025-06-30 13F/A-1 ELEDON PHARMACEUTICALS COM 28617K101 101,878 31,878 0 0.0001
2025-08-13 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 101,878 31,878 0 0.0000
2026-03-17 2025-03-31 13F/A-1 ELEDON PHARMACEUTICALS COM 28617K101 70,000 0 0.00 237 -17.71 0.0001
2025-05-15 2025-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 70,000 0 0 0.0001
2026-03-19 2024-12-31 13F/A-1 ELEDON PHARMACEUTICALS COM 28617K101 70,000 70,000 288 0.0001
2025-02-13 2024-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 70,000 70,000 0 0.0001
2019-08-14 2019-06-30 13F NOVUS THERAPEUTICS COM 67011N105 0 -78 -100.00 0 0.0000
2019-05-15 2019-03-31 13F NOVUS THERAPEUTICS COM 67011N105 78 76 3,800.00 0 0.0000
2019-02-14 2018-12-31 13F NOVUS THERAPEUTICS COM 67011N105 2 0 0.00 0 0.0000
2018-11-14 2018-09-30 13F NOVUS THERAPEUTICS COM 67011N105 2 0 0.00 0 0.0000
2018-08-14 2018-06-30 13F NOVUS THERAPEUTICS COM 67011N105 2 -18 -90.00 0 0.0000
2018-05-15 2018-03-31 13F NOVUS THERAPEUTICS COM 67011N105 20 18 900.00 0 0.0000
2018-02-14 2017-12-31 13F NOVUS THERAPEUTICS COM 67011N105 2 0 0.00 0 0.0000
2017-11-14 2017-09-30 13F NOVUS THERAPEUTICS COM 67011N105 2 -46 -95.83 0 0.0000
2017-08-14 2017-06-30 13F NOVUS THERAPEUTICS COM 67011N105 48 -12,228 -99.61 0 -100.00
2017-05-15 2017-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 12,276 8,268 206.29 10 150.00 0.0000
2017-02-14 2016-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 4,008 3,097 339.96 4 300.00 0.0000
2016-11-14 2016-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 911 610 202.66 1 -50.00 0.0000
2016-08-12 2016-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 301 196 186.67 2 100.00 0.0000
2016-05-16 2016-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 105 -335 -76.14 1 -75.00 0.0000
2016-02-12 2015-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 440 391 797.96 4 0.0000
2015-11-13 2015-09-30 13F TOKAI PHARMACEUTICALS COM 88907J107 49 -133 -73.08 0 -100.00
2015-08-14 2015-06-30 13F TOKAI PHARMACEUTICALS COM 88907J107 182 0 0.00 2 0.00 0.0000
2015-05-19 2015-03-31 13F/A-1 TOKAI PHARMACEUTICALS COM 88907J107 182 -298 -62.08 2 -71.43 0.0000
2015-05-14 2015-03-31 13F TOKAI PHARMACEUTICALS COM 88907J107 182 2
2015-02-13 2014-12-31 13F TOKAI PHARMACEUTICALS COM 88907J107 480 480 7 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.